Effects of TENS in Pain During Application of Carboxytherapy in Patients With Gynoid Lipodystrophy

NCT02743403 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2017-05-04

No results posted yet for this study

Summary

The project aims to compare the use of carboxiterapia ( therapeutic administration of carbon dioxide) with the use of active TENS and placebo TENS using the VAS scale as a parameter. The therapy used was started in the 30s , with carbonated water baths, and , lately, is involved in the therapeutic arsenal of numerous diseases , Both for treatment of diseases when for aesthetic treatments , especially for the gynoid lipodystrophy. However, the therapy presents CO2 in clinical practice, limiting factors for its use , such as pain at the injection site , small bruises or welts due to several punctures and feeling of crepitus. To try to combat these " side effects " that can last up to 30 minutes, the TENS was used in order to determine whether the use of this electric current helps at improvement of discomfort.

Conditions

Interventions

DEVICE

Neurodyn Portable activeTENS, IBRAMED®

Randomization and secret Allocation active TENS (GI / n = 27)

DEVICE

Neurodyn Portable placeboTENS, IBRAMED®

Randomization and secret Allocation placebo TENS (GII / n = 27)

DEVICE

Carboxyderm S20-1C

Randomization and secret Allocation control group (CG / n = 27).

Sponsors & Collaborators

  • Universidade Cidade de Sao Paulo

    lead OTHER

Principal Investigators

  • Richard E Liebano, PhD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-04-30
Completion
2016-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02743403 on ClinicalTrials.gov